Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01974752
Title Selumetinib (AZD6244: ARRY-142886) (Hyd-Sulfate) in Metastatic Uveal Melanoma (SUMIT)
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors AstraZeneca
Indications

uveal melanoma

Therapies

Dacarbazine + Selumetinib

Age Groups: adult
Covered Countries USA | CAN


No variant requirements are available.